6. Glycemic Targets: Standards of Medical Care in Diabetes—2019
The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes” includes ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations, please refer to the Standards of Care Introduction. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · cited 1×
“pharmacotherapy) and in all-cause mortality (13% and 27%, respectively) (22).”
BackgroundIntensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0033 · Cited by 3,518 · cited 1×
“If the patient is meeting A1C target, consider one of three strategies (39):”
Background
Cited by
KDIGO 2020 Clinical practice guideline for diabetes management in chronic kidney disease
de Boer, I. H., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.06.019 · Cited by 1,399
Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
Brown, S. A., Kovatchev, B. P., Raghinaru, D., Lum, J. W., Buckingham, B. A., Kudva, Y. C., Laffel, L. M., Levy, C. J., Pinsker, J. E., Wadwa, R. P., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1907863 · Cited by 1,030
Laffel, L. M., Kanapka, L. G., Beck, R. W., Bergamo, K., Clements, M. A., Criego, A., DeSalvo, D. J., Goland, R., Hood, K., Liljenquist, D., et al. (2020) · JAMA · doi:10.1001/jama.2020.6940 · Cited by 443
Capehorn, M. S., Catarig, A.-M., Furberg, J. K., Janez, A., Price, H. C., Tadayon, S., Vergès, B., & Marre, M. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.101117 · Cited by 412
Maiorino, M. I., Signoriello, S., Maio, A., Chiodini, P., Bellastella, G., Scappaticcio, L., Longo, M., Giugliano, D., & Esposito, K. (2020) · Diabetes Care · doi:10.2337/dc19-1459 · Cited by 364
Arnold, S. V., Bhatt, D. L., Barsness, G. W., Beatty, A. L., Deedwania, P. C., Inzucchi, S. E., Kosiborod, M., Leiter, L. A., Lipska, K. J., Newman, J. D., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000766 · Cited by 304
Yun, J.-S., & Ko, S.-H. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154838 · Cited by 292
de Boer, I. H., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.06.024 · Cited by 278
Inflammatory Targets in Diabetic Nephropathy
Donate-Correa, J., Luis-Rodríguez, D., Martín-Núñez, E., Tagua, V. G., Hernández-Carballo, C., Ferri, C., Rodríguez-Rodríguez, A. E., Mora-Fernández, C., & Navarro-González, J. F. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020458 · Cited by 245
McTigue, K. M., Wellman, R., Nauman, E., Anau, J., Coley, R. Y., Odor, A., Tice, J., Coleman, K. J., Courcoulas, A., Pardee, R. E., et al. (2020) · JAMA Surgery · doi:10.1001/jamasurg.2020.0087 · Cited by 229
Effects of Probiotics on Metabolic Syndrome: A Systematic Review of Randomized Clinical Trials
Tenorio-Jiménez, C., Martínez-Ramírez, M. J., Gil, Á., & Gómez-Llorente, C. (2020) · Nutrients · doi:10.3390/nu12010124 · Cited by 206
Abreu, A., Frederix, I., Dendale, P., Janssen, A., Doherty, P., Piepoli, M. F., Völler, H., Davos, C. H., Reviewers:, T. S. P. A. R. S. O. E., & Ambrosetti, M. (2021) · European Journal of Preventive Cardiology · doi:10.1177/2047487320924912 · Cited by 187
US Emergency Department Visits Attributed to Medication Harms, 2017-2019
Budnitz, D. S., Shehab, N., Lovegrove, M. C., Geller, A. I., Lind, J. N., & Pollock, D. A. (2021) · JAMA · doi:10.1001/jama.2021.13844 · Cited by 178
Teo, E., Hassan, N., Tam, W., & Koh, S. (2022) · Diabetologia · doi:10.1007/s00125-021-05648-4 · Cited by 186
RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020
Madhu, S., Chawla, R., Makkar, B., Ghosh, S., Saboo, B., & Kalra, S. (2020) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_225_20 · Cited by 167
Positioning time in range in diabetes management
Advani, A. (2020) · Diabetologia · doi:10.1007/s00125-019-05027-0 · Cited by 170
Navaneethan, S. D., Zoungas, S., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Liew, A., Michos, E. D., Olowu, W. A., Sadusky, T., et al. (2021) · Annals of Internal Medicine · doi:10.7326/m20-5938 · Cited by 163
Messer, L. H., Berget, C., Vigers, T., Pyle, L., Geno, C., Wadwa, R. P., Driscoll, K. A., & Forlenza, G. P. (2020) · Pediatric Diabetes · doi:10.1111/pedi.12971 · Cited by 161
Rein, M., Ben-Yacov, O., Godneva, A., Shilo, S., Zmora, N., Kolobkov, D., Cohen-Dolev, N., Wolf, B.-C., Kosower, N., Lotan-Pompan, M., et al. (2022) · BMC Medicine · doi:10.1186/s12916-022-02254-y · Cited by 149
Hydrogels in Emerging Technologies for Type 1 Diabetes
Fuchs, S., Ernst, A. U., Wang, L., Shariati, K., Wang, X., Liu, Q., & Ma, M. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01062 · Cited by 171
Wada, E., Onoue, T., Kobayashi, T., Handa, T., Hayase, A., Ito, M., Furukawa, M., Okuji, T., Okada, N., Iwama, S., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001115 · Cited by 157
Benefits and harms of intensive glycemic control in patients with type 2 diabetes
Rodriguez-Gutierrez, R., Gonzalez-Gonzalez, J. G., Zuñiga-Hernandez, J. A., & McCoy, R. G. (2019) · BMJ · doi:10.1136/bmj.l5887 · Cited by 152
Saxena, A. R., Frias, J. P., Brown, L. S., Gorman, D. N., Vasas, S., Tsamandouras, N., & Birnbaum, M. J. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.14493 · Cited by 149
2020 Clinical practice guidelines for Acute coronary syndrome without ST segment elevation
Барбараш, О. Л., Duplyakov, D. V., Zateischikov, D. A., Панченко, Е. П., Shakhnovich, R. M., Yavelov, I. S., Yakovlev, A. N., Sa, A., Alekyan, B. G., Викторович, А. М., et al. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4449 · Cited by 149
Efficacy and Safety of Dapagliflozin in the Elderly: Analysis From the DECLARE–TIMI 58 Study
Cahn, A., Mosenzon, O., Wiviott, S. D., Rozenberg, A., Yanuv, I., Goodrich, E. L., Murphy, S. A., Bhatt, D. L., Leiter, L. A., McGuire, D. K., et al. (2020) · Diabetes Care · doi:10.2337/dc19-1476 · Cited by 136
HbA1c: More than just a number
Wang, M., & Hng, T.-M. (2021) · Australian Journal of General Practice · doi:10.31128/ajgp-03-21-5866 · Cited by 131
BAJAJ, H. S., Bergenstal, R. M., Christoffersen, A., Davies, M. J., Gowda, A., Isendahl, J., Lingvay, I., Senior, P. A., Silver, R., Trevisan, R., et al. (2021) · Diabetes Care · doi:10.2337/dc20-2877 · Cited by 132
van Doorn, W. P. T. M., Foreman, Y. D., Schaper, N. C., Savelberg, H. H. C. M., Koster, A., van der Kallen, C. J. H., Wesselius, A., Schram, M. T., Henry, R. M. A., Dagnelie, P. C., et al. (2021) · PLOS ONE · doi:10.1371/journal.pone.0253125 · Cited by 104
Zou, Y., Chu, Z., Guo, J., Liu, S., Ma, X., & Guo, J. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115103 · Cited by 129
Metabolic Syndrome and COVID 19: Endocrine-Immune-Vascular Interactions Shapes Clinical Course
Bansal, R., Gubbi, S., & Muniyappa, R. (2020) · Endocrinology · doi:10.1210/endocr/bqaa112 · Cited by 113
Kramer, J. R., Natarajan, Y., Dai, J., Yu, X., Li, L., El‐Serag, H. B., & Kanwal, F. (2022) · Hepatology · doi:10.1002/hep.32244 · Cited by 113
Mendes, R., Sousa, N., Themudo-Barata, J. L., & Reis, V. M. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16214163 · Cited by 126
Hypoglycemia in patient with type 2 diabetes treated with insulin: it can happen
Heller, S. R., Peyrot, M., Oates, S. K., & Taylor, A. D. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001194 · Cited by 101
SGLT2 Inhibitors: Nephroprotective Efficacy and Side Effects
Garofalo, C., Borrelli, S., Liberti, M., Andreucci, M., Conte, G., Minutolo, R., Provenzano, M., & Nicola, L. D. (2019) · Medicina · doi:10.3390/medicina55060268 · Cited by 106
Sherr, J. L., Buckingham, B. A., Forlenza, G. P., Galderisi, A., Ekhlaspour, L., Wadwa, R. P., Carria, L., Hsu, L., Berget, C., Peyser, T. A., et al. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0286 · Cited by 92
Adane, T., Melku, M., Worku, Y. B., Fasil, A., Aynalem, M., Kelem, A., & Getawa, S. (2023) · Journal of Diabetes Research · doi:10.1155/2023/3117396 · Cited by 99
Nanomedicine-Based Strategies for Diabetes: Diagnostics, Monitoring, and Treatment
Lemmerman, L. R., Das, D., Higuita‐Castro, N., Mirmira, R. G., & Gallego‐Perez, D. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.02.001 · Cited by 83
Lage, M. J., & Boye, K. S. (2020) · Current Medical Research and Opinion · doi:10.1080/03007995.2020.1787971 · Cited by 73
Renard, E., Ikegami, H., Daher Vianna, A. G., Pozzilli, P., Brette, S., Bosnyak, Z., Lauand, F., Peters, A., Pilorget, V., Jurišić‐Eržen, D., et al. (2021) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3430 · Cited by 77
Stote, K. S., Wilson, M. M., Hallenbeck, D., Thomas, K., Rourke, J. M., Sweeney, M. I., Gottschall‐Pass, K. T., & Gosmanov, A. R. (2020) · Current Developments in Nutrition · doi:10.1093/cdn/nzaa030 · Cited by 92
Engström, M. S., Leksell, J. K., Johansson, U., Borg, S., Palaszewski, B., Franzén, S., Guðbjörnsdóttir, S., & Eeg‐Olofsson, K. (2019) · Health and Quality of Life Outcomes · doi:10.1186/s12955-019-1212-z · Cited by 82
Diabetes-Related Distress and Depression in Saudis with Type 2 Diabetes
Alzughbi, T., Badedi, M., Darraj, H. A., Hummadi, A. A., Jaddoh, S., Solan, Y., & Sabai, A. I. (2020) · Psychology Research and Behavior Management · doi:10.2147/prbm.s255631 · Cited by 76
Parviniannasab, A. M., Faramarzian, Z., Hosseini, S. A., Hamidizadeh, S., & Bijani, M. (2024) · BMC Public Health · doi:10.1186/s12889-024-18022-x · Cited by 86
“Type 2 diabetes (T2D) can cause various macrovascular and microvascular physical complications [1].”
BackgroundChoi, S. E., Sima, C., & Pandya, A. (2019) · Diabetes Care · doi:10.2337/dc19-1201 · Cited by 73
Primary Care and Food Bank Collaboration to Address Food Insecurity: A Pilot Randomized Trial
Ferrer, R. L., Neira, L.-M., Garcia, G. L. D. L., Cuellar, K., & Rodriguez, J. (2019) · Nutrition and Metabolic Insights · doi:10.1177/1178638819866434 · Cited by 73
Romão, B., Falcomer, A. L., Palos, G., Cavalcante, S., Botelho, R. B. A., Nakano, E. Y., Raposo, A., Shakeel, F., Alshehri, S., Mahdi, W. A., et al. (2021) · Foods · doi:10.3390/foods10030506 · Cited by 71
Ke, C., Stukel, T. A., Shah, B. R., Lau, E., Ma, R. C., So, W.-Y., Kong, A. P., Chow, E., Chan, J. C. N., & Luk, A. (2020) · PLOS Medicine · doi:10.1371/journal.pmed.1003316 · Cited by 57
Ponirakis, G., Elhadd, T. A., Al‐Ozairi, E., Brema, I. A., Chinnaiyan, S., Taghadom, E., Kandari, J. A., Wotayan, R. A., Ozairi, A. A., Aljohani, N., et al. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13815 · Cited by 75
Continuous Glucose Monitoring: A Review of Available Systems.
Funtanilla, V. D., Candidate, P., Caliendo, T., & Hilas, O. (2019) · PubMed · Cited by 69
Brew‐Sam, N., Chhabra, M., Parkinson, A., Hannan, K., Brown, E., Pedley, L., Brown, K., Wright, K., Pedley, E., Nolan, C. J., et al. (2021) · JMIR Diabetes · doi:10.2196/20973 · Cited by 70
Krishnakumar, A., Verma, R., Chawla, R., Sosale, A., Saboo, B., Joshi, S., Shaikh, M., Shah, A., Kolwankar, S., & Mattoo, V. (2021) · Journal of Medical Internet Research · doi:10.2196/17908 · Cited by 72
“A 0.5% to 1% change in HbA 1c level is considered clinically significant to reduce the risk of comorbid conditions; even the US Food and Drug Administration requires a 0.4% change in HbA 1c level for drug evaluations [24].”
InfluentialPetrovski, G., Khalaf, F. A., Campbell, J., Day, E., Almajaly, D., Hussain, K., Pasha, M., Umer, F., Hamdan, M., & Khalifa, A. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-00996-7 · Cited by 72
Diabetes Diagnosis and Control: Missed Opportunities to Improve Health
Cowie, C. C. (2019) · Diabetes Care · doi:10.2337/dci18-0047 · Cited by 68
Bousquet, J. J., Antó, J. M., Sousa‐Pinto, B., Czarlewski, W., Bedbrook, A., Haahtela, T., Klimek, L., Pfaar, O., Kuna, P., Kupczyk, M., et al. (2023) · Clinical and Translational Allergy · doi:10.1002/clt2.12215 · Cited by 65
Averkov, O. V., HARUTYUNYAN, G., Duplyakov, D. V., Константинова, Е. В., Nikulina, N. N., Shakhnovich, R. M., Yavelov, I. S., Yakovlev, A. N., Abugov, S. A., Alekyan, B. G., et al. (2025) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6319 · Cited by 77
Importance of Postprandial Glucose in Relation to A1C and Cardiovascular Disease
Hershon, K. S., Hirsch, B. R., & Odugbesan, O. (2019) · Clinical Diabetes · doi:10.2337/cd18-0040 · Cited by 67
Monnier, L., Wojtusciszyn, A., Molinari, N., Colette, C., Renard, É., & Owens, D. R. (2020) · Diabetes Care · doi:10.2337/dc19-1549 · Cited by 68
Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV study
Samson, S. L., Gu, F., Feldt-Rasmussen, U., Zhang, S., Yu, Y., Witek, P., Kalra, P., Pedroncelli, A. M., Pultar, P., Jabbour, N., et al. (2021) · Pituitary · doi:10.1007/s11102-021-01161-4 · Cited by 60
Petrovski, G., Al Khalaf, F., Campbell, J., Umer, F., Almajaly, D., Hamdan, M., & Hussain, K. (2021) · Acta Diabetologica · doi:10.1007/s00592-020-01607-4 · Cited by 56
Alghamdi, A., Alghamdi, K. A., Jenkins, R. O., Alghamdi, M. N., & Haris, P. I. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00825-x · Cited by 66
Diabetes mellitus type 2 in adults
Dedov, I. I., Shestakova, M. V., Mayorov, A. Y., Шамхалова, М. Ш., Sukhareva, O. Y., Galstyan, G. R., Tokmakova, A. Y., Nikonova, T. V., Surkova, E. V., Кононенко, И. В., et al. (2020) · Diabetes Mellitus · doi:10.14341/dm12507 · Cited by 69
Imai, C., Li, L., Hardie, R., & Georgiou, A. (2021) · BMJ Quality & Safety · doi:10.1136/bmjqs-2020-012026 · Cited by 61
Gupta, S. K., Lakshmi, P. V. M., Kaur, M., & Rastogi, A. (2020) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1684_20 · Cited by 64
Artificial pancreas under stable pulsatile MPC: Improving the closed-loop performance
Abuin, P., Rivadeneira, P. S., Ferramosca, A., & González, A. H. (2020) · Journal of Process Control · doi:10.1016/j.jprocont.2020.06.009 · Cited by 61
Li, A., Su, X., Hu, S., & Wang, Y. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110605 · Cited by 49
Jendle, J., Pöhlmann, J., de Portu, S., Smith-Palmer, J., & Roze, S. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0328 · Cited by 52
Dhaliwal, R., Hans, D. B., Hattersley, G., Mitlak, B., Fitzpatrick, L. A., Wang, Y., Schwartz, A. V., Miller, P. D., & Josse, R. G. (2020) · JBMR Plus · doi:10.1002/jbm4.10346 · Cited by 58
Blonde, L., Belousova, L., Fainberg, U., Garcia‐Hernandez, P. A., Jain, S. M., Kaltoft, M. S., Mosenzon, O., Nafach, J., Palle, M. S., & Rea, R. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13978 · Cited by 54
Pulok, M. H., Gool, K. V., Hajizadeh, M., Allin, S. M., & Hall, J. P. (2019) · The European Journal of Health Economics · doi:10.1007/s10198-019-01118-2 · Cited by 61
Cardiovascular autonomic neuropathy: A silent killer with long reach
Ang, L., Dillon, B., Mizokami-Stout, K., & Pop-Busui, R. (2020) · Autonomic Neuroscience · doi:10.1016/j.autneu.2020.102646 · Cited by 53
Kamrul-Hasan, A. B. M., Paul, A., Amin, M. N., Gaffar, M. A. J., Asaduzzaman, M., Saifuddin, M., Mustari, M., Alam, M. J., Shahid, M. M., Nahid-Ul-Haque, K., et al. (2020) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2020.16.1.41 · Cited by 52
Dulaglutide: A Review in Type 2 Diabetes
Scott, L. J. (2020) · Drugs · doi:10.1007/s40265-020-01260-9 · Cited by 56
Clinical recommendations for the use of the ambulatory glucose profile in diabetes care
Kröger, J., Reichel, A., Siegmund, T., & Ziegler, R. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819883032 · Cited by 51
McCoy, R. G., Lipska, K. J., Van Houten, H. K., & Shah, N. D. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001007 · Cited by 51
Segura-Cerda, C. A., López-Romero, W., & Flores‐Valdez, M. A. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00342 · Cited by 51
Ceriello, A., de Valk, H. W., Guerci, B., Haak, T., Owens, D. R., Canobbio, M., Fritzen, K., Stautner, C., & Schnell, O. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108053 · Cited by 52
Treatment of type 2 diabetes by targeting interleukin-1: a meta-analysis of 2921 patients
Kataria, Y., Ellervik, C., & Mandrup-Poulsen, T. R. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00743-6 · Cited by 56
Mirza, S., Khan, A. A., Kheraif, A. A. A., Khan, S. Z., & Shafqat, S. S. (2019) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2019.08.003 · Cited by 49
Yonekawa, Y., Modi, Y. S., Kim, L. A., Skondra, D., Kim, J. E., & Wykoff, C. C. (2020) · Journal of VitreoRetinal Diseases · doi:10.1177/2474126419893829 · Cited by 55
The many faces of diabetes. Is there a need for re-classification? A narrative review
Sakran, N., Graham, Y. N. H., Pintar, T., Yang, W., Kassir, R., Willigendael, E. M., Singhal, R., Kooreman, Z. E., Ramnarain, D., Mahawar, K. K., et al. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00927-y · Cited by 55
Palella, E., Cimino, R., Pullano, S. A., Fiorillo, A. S., Gulletta, E., Brunetti, A., Foti, D. P., & Greco, M. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17010300 · Cited by 48
Fernández‐Fernández, B., Fernández-Prado, R., Górriz, J. L., Martínez‐Castelao, A., Navarro‐González, J. F., Porrini, E., Soler, M. J., & Ortíz, A. (2019) · Clinical Kidney Journal · doi:10.1093/ckj/sfz070 · Cited by 48
Negera, G. Z., Weldegebriel, B., & Fekadu, G. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s249163 · Cited by 48
Kovatchev, B. P., Kollar, L., Anderson, S. M., Barnett, C., Breton, M. D., Carr, K., Gildersleeve, R., Oliveri, M. C., Wakeman, C. A., & Brown, S. A. (2020) · The Lancet Digital Health · doi:10.1016/s2589-7500(19)30218-3 · Cited by 47
Bennich, B. B., Munch, L., Overgaard, D., Konradsen, H., Knop, F. K., Røder, M. E., Vilsbøll, T., & Egerod, I. (2019) · Journal of Advanced Nursing · doi:10.1111/jan.14256 · Cited by 57
Grabowski, D., Overgaard, M., Meldgaard, J., Johansen, L. B., & Willaing, I. (2021) · Diabetology · doi:10.3390/diabetology2010001 · Cited by 46
Saxena, A. R., Frias, J. P., Gorman, D. N., Lopez, R. N., Andrawis, N., Tsamandouras, N., & Birnbaum, M. J. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15168 · Cited by 45
SGLT inhibitors for type 1 diabetes: proceed with extreme caution
Wolfsdorf, J. I., & Ratner, R. E. (2019) · Diabetes Care · doi:10.2337/dci19-0008 · Cited by 45
Thieu, V. T., Mitchell, B. D., Varnado, O. J., & Frier, B. M. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13941 · Cited by 44
RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020
Chawla, R., Madhu, S. V., Makkar, B. M., Ghosh, S. K., Saboo, B., Kalra, S., & On behalf of RSSDI-ESI Consensus Group (2020) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-020-00819-2 · Cited by 57
Carlson, A. L., Kanapka, L. G., Miller, K. M., Ahmann, A. J., Chaytor, N. S., Fox, S., Kiblinger, L., Kruger, D., Levy, C. J., Peters, A. L., et al. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819894974 · Cited by 43
Lin, Y. K., Groat, D., Chan, O., Hung, M., Sharma, A., Varner, M. W., Gouripeddi, R., Facelli, J. C., & Fisher, S. J. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvz005 · Cited by 39
Zezza, M., Kosinski, C., Mekoguem, C., Marino, L., Chtioui, H., Pitteloud, N., & Lamine, F. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0467-z · Cited by 46
Petruželková, L., Jiranova, P., Šoupal, J., Kozak, M., Plachý, L., Neuman, V., Průhová, Š., Obermannová, B., Koloušková, S., & Šumník, Z. (2021) · Pediatric Diabetes · doi:10.1111/pedi.13190 · Cited by 46
Paiman, E. H. M., van Eyk, H. J., van Aalst, M. M. A., Bizino, M. B., van der Geest, R. J., Westenberg, J. J. M., Geelhoed‐Duijvestijn, P. H., Kharagjitsingh, A. V., Rensen, P. C. N., Smit, J. W. A., et al. (2020) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27009 · Cited by 41
Foreman, Y. D., Brouwers, M. C. G. J., Kallen, C., Pagen, D. M. E., van Greevenbroek, M. M. J., Henry, R. M. A., Koster, A., Wesselius, A., Schaper, N. C., & Stehouwer, C. D. A. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0385 · Cited by 47
Initial Glycemic Control and Care Among Younger Adults Diagnosed With Type 2 Diabetes
Gopalan, A., Mishra, P., Alexeeff, S. E., Blatchins, M. A., Kim, E., Man, A., Karter, A. J., & Grant, R. W. (2020) · Diabetes Care · doi:10.2337/dc19-1380 · Cited by 33
Alshehri, M. M., Alothman, S. A., Alenazi, A. M., Rucker, J. L., Phadnis, M. A., Miles, J. M., Siengsukon, C. F., & Kluding, P. M. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00612-6 · Cited by 41
Nuhoho, S., Gupta, J., Hansen, B. B., Fletcher-Louis, M., Dang-Tan, T., & Paine, A. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-00706-y · Cited by 41
Bergenstal, R. M., Peyrot, M., Dreon, D. M., Aroda, V. R., Bailey, T. S., Brazg, R. L., Frias, J. P., Johnson, M. L., Klonoff, D. C., Kruger, D. F., et al. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0298 · Cited by 37
Metadata
- Authors
- American Diabetes Association
- Corresponding author
- American Diabetes Association
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2018-12-07
- Volume
- 42
- Issue
- Supplement_1
- Pages
- S61-S70
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4250208868
- Cited by
- 655
- References
- 59
- Citations by year
- 2026: 17 · 2025: 27 · 2024: 35 · 2023: 57 · 2022: 85 · 2021: 117 · 2020: 202 · 2019: 112
- FWCI
- 16.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- glycemic targets, glycemic control, diabetes management, clinical guidelines, quality of care, treatment goals
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Societies, Medical, United States, Practice Guidelines as Topic, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.